Seguir
Mustafa Karabiçici
Mustafa Karabiçici
Dirección de correo verificada de cshs.org
Título
Citado por
Citado por
Año
Regulation of Wnt signaling pathways at the plasma membrane and their misregulation in cancer
Y Azbazdar, M Karabicici, E Erdal, G Ozhan
Frontiers in cell and developmental biology 9, 631623, 2021
652021
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
M Karabicici, S Alptekin, Z Fırtına Karagonlar, E Erdal
Molecular Oncology 15 (8), 2185-2202, 2021
552021
A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM/CD133 nonStem Cells into EpCAM+/CD133+ Liver Cancer Stem Cells in HCC Cell …
Z Firtina Karagonlar, S Akbari, M Karabicici, E Sahin, S Tercan Avci, ...
Cells 9 (5), 1198, 2020
452020
Changes in Wnt and TGF-β signaling mediate the development of regorafenib resistance in hepatocellular carcinoma cell line HuH7
M Karabicici, Y Azbazdar, G Ozhan, S Senturk, Z Firtina Karagonlar, ...
Frontiers in cell and developmental biology 9, 639779, 2021
322021
Misregulation of Wnt signaling pathways at the plasma membrane in brain and metabolic diseases
M Karabicici, Y Azbazdar, E Iscan, G Ozhan
Membranes 11 (11), 844, 2021
112021
Investigation of methylation profiles of TP53, caspase 9, caspase 8, caspase 3 genes treated with DNA methyl transferase inhibitor (DNMTi) zebularine (ZEB) and caffeic acid …
O Eroglu, EG Celik, H Kaya, M Celen, M Karabicici, E Karacoban
Journal of Cancer Therapy 10 (1), 69-85, 2019
72019
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth
Y Azbazdar, Y Demirci, G Heger, D Ipekgil, M Karabicici, G Ozhan
Molecular Oncology 17 (11), 2314-2336, 2023
42023
Human liver organoid models for assessment of drug toxicity at the preclinical stage
M Karabicici, S Akbari, O Ertem, M Gumustekin, E Erdal
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023
22023
Fibrotic Phenotype in CRISPR knockout p53 of Hepatic Organoids within a Pro-Carcinogenic Microenvironment
E ERDAL, M Karabicici, S Akbari, C Calıskan, C Celiker, O Oz, L Binokay, ...
2024
Genetic ablation of p53 at the onset of HCC triggers tumor initiation via the CD24-TGFB axis in a pro-carcinogenic microenvironment
M Karabicici, O Oz, E Erdal
FEBS OPEN BIO 12, 69-69, 2022
2022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–10